| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/14/2005 | US6906084 Indole derivatives as factor Xa inhibitors |
| 06/14/2005 | US6906082 Cholesteryl ester transfer protein inhibitor; anticholesterol agents, cardiovascular disorders; synergistic mixture |
| 06/14/2005 | US6906081 For treatment of Alzheimer's disease, learning disabilities |
| 06/14/2005 | US6906080 Antiinflammatory agents, analgesics, drug abuse, alcoholism |
| 06/14/2005 | US6906079 Method and reagents for N-alkylating ureides |
| 06/14/2005 | US6906078 Method of using (H+/K+) ATPase inhibitors as antiviral agents |
| 06/14/2005 | US6906077 Topically or intraocularly administering AIT-082 (neotrofin), idebenone, ONO-2506, CB-1093, NS521 ((1-(1-butyl)-4-(2-oxo-1-benzimidazolone)piperidine, SS-701, KT-711 and/or clenbuterol; neurodegenerative disorders |
| 06/14/2005 | US6906076 Inactivating a nuclear localization signal of a protein by contacting the protein with a compound that binds reversibly; parasiticides; viricides |
| 06/14/2005 | US6906075 Contacting a sample with substituted benzoimidazole analogues under conditions that permit binding of such analogue to melanin concentrating hormone (MCH) receptor to determine the presence and absence of MCH |
| 06/14/2005 | US6906073 Piperazine CCR-3 receptor antagonists |
| 06/14/2005 | US6906072 Central nervous system disorders |
| 06/14/2005 | US6906069 LXR modulators |
| 06/14/2005 | US6906068 Substituted polycyclic aryl and heteroaryl 1,2,4 - triazinones useful as anticoagulants |
| 06/14/2005 | US6906067 Block cytokine production via inhibition of p38 kinase; triamino-s-triazine compounds; treating rheumatoid arthritis |
| 06/14/2005 | US6906065 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases |
| 06/14/2005 | US6906064 Administering inhibitors of human epidermal growth factor receptor tyrosine kinase and cGMP-specific phosphodiesterase; side effects reduction |
| 06/14/2005 | US6906063 For therapy and prophylaxis of thrombosis in a mammal |
| 06/14/2005 | US6906062 Stable colour at ambient conditions of storage; treating psychological disorders |
| 06/14/2005 | US6906061 Therapeutic agent of hypertension, a therapeutic agent of angina pectoris, a suppressive agent of cerebrovascular contraction, a therapeutic agent of asthma, a therapeutic agent of peripheral circulation disorder, a prophylactic |
| 06/14/2005 | US6906060 Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]-pyrazines and decahydropyrazino[1,2-a]azepines |
| 06/14/2005 | US6906059 Administering cardioprotective amount of a benzazepin-N-acetic acid derivative for inhibiting or treating heart damage induced by a cardiotoxic medicamet in a mammal |
| 06/14/2005 | US6906058 Prevent bile acid transportation; anticholesterol agents |
| 06/14/2005 | US6906057 Anticholesterol agents; farnesyl protein transferase inhibitors |
| 06/14/2005 | US6906056 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 06/14/2005 | US6906055 Bactericides; antibiotiucs; dissolving in water, crystallization; Ceftaroline fosamil acetate |
| 06/14/2005 | US6906054 Alkylidene or dialkylidene cephalosporin-type derivatives |
| 06/14/2005 | US6906053 Antiarthritic agents; antiulcer agents; osteoporosis; antiinflammatory agents; antitumor and anticancer agents |
| 06/14/2005 | US6906052 Chelation of iron in urine |
| 06/14/2005 | US6906051 Viricides, fungicides, microbiocides, osteoporosis |
| 06/14/2005 | US6906049 Contraceptive medicine based on a progestational agent and an oestrogen and preparation method |
| 06/14/2005 | US6906048 N-acetylcolchinol-O-phosphate combination therapies with vascular damaging activity |
| 06/14/2005 | US6906047 Aqueous ifosfamide composition |
| 06/14/2005 | US6906044 Regeneration of articular cartilage damaged by grade I and II osteoarthritis by means of the intraarticular application of a mixture of sodium hyaluronate and chondroitin sulfate in a gel vehicle |
| 06/14/2005 | US6906042 Micelles |
| 06/14/2005 | US6906041 Treatment of immune diseases |
| 06/14/2005 | US6906040 Method for reducing toxicity of combined chemotherapies |
| 06/14/2005 | US6906038 Reducing side effects of radiation and chemotherapy, via the administration of an oral rehydration solution of sodium, potassium and citrate |
| 06/14/2005 | US6906026 Methods for treating conditions associated with the accumulation of excess extracellular matrix |
| 06/14/2005 | US6905709 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
| 06/14/2005 | US6905708 Bupropion hydrochloride in protective coating; side effect reduction |
| 06/14/2005 | US6905707 Controlling concentration of enzyme inhibitor in blood; enteric coating |
| 06/14/2005 | US6905706 Crassulaceae special extracts, Carpediol, containing 2-(4-hydroxyphenyl)ethyl-beta-d-glucopyranoside or 3-(6-o-(alpha-1-arabinopyranosyl)-beta-d-glucopyranosyl)-beta-d -glucopyranosyl)-oxy-1-phenylpropene |
| 06/14/2005 | US6905702 Methods for regulating blood glucose and appetite suppression in type 2 diabetics |
| 06/14/2005 | US6905701 Formulations for transmucosal vaginal delivery of bisphosphonates |
| 06/14/2005 | US6905692 Suitable for topical application to skin or mucosal membranes of a mammal, which are utilized to inhibit the growth of bacteria, yeasts, fungi, viruses |
| 06/14/2005 | US6905677 Synergistic mixture of nucleoside and interferons |
| 06/14/2005 | US6905675 Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions |
| 06/14/2005 | US6905671 Using isotope of 5-aminolevulinic acid |
| 06/14/2005 | US6905669 Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase |
| 06/14/2005 | US6905654 Method and apparatus for reducing static charges during polymerization of olefin polymers |
| 06/14/2005 | US6905455 Radioactive member and method of making |
| 06/14/2005 | CA2420576C Immunoregulatory compounds, derivatives thereof and their use |
| 06/14/2005 | CA2361584C Anticonvulsant derivatives useful in treating autism |
| 06/14/2005 | CA2359080C Method for reducing 3-dimethylamino-2-phenylpropion-acid ethyl ester-content in solutions of 2-dimethylamino-1-phenyl-3-cyclohexene-1-carboxylic acid ethyl ester |
| 06/14/2005 | CA2346567C Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin |
| 06/14/2005 | CA2339782C Polyamine treatment of neurological disorders |
| 06/14/2005 | CA2333703C Isothiazole derivatives useful as anticancer agents |
| 06/14/2005 | CA2327285C Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same |
| 06/14/2005 | CA2304967C 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 06/14/2005 | CA2285463C A combination therapy for hiv infections |
| 06/14/2005 | CA2274591C Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them |
| 06/14/2005 | CA2258893C Anticonvulsant sulfamate derivatives useful in treating obesity |
| 06/14/2005 | CA2248582C Process for producing efonidipine hydrochloride preparations |
| 06/14/2005 | CA2246708C Vaccine for b-cell malignancies |
| 06/14/2005 | CA2234096C 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 06/14/2005 | CA2163122C Positive inotropic and lusitropic pyrroloquinolinone derivatives |
| 06/14/2005 | CA2155952C Novel process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
| 06/14/2005 | CA2155323C Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof |
| 06/14/2005 | CA2150229C Nitric esters having a pharmacological activity and process for their preparation |
| 06/14/2005 | CA2136008C Substituted (arylalkylaminobenzyl)amino-propionamide derivatives and process for their preparation |
| 06/14/2005 | CA2112017C Use of benzothiophenes for lowering serum cholesterol |
| 06/14/2005 | CA2098842C Use of host cell phospholipids for inhibiting microbial colonization |
| 06/14/2005 | CA2086908C Substituted n-phenyl-2-cyano-3-hydroxy-enamides |
| 06/09/2005 | WO2005052187A1 Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway |
| 06/09/2005 | WO2005052185A1 Detection of no by using guanylyl cyclase and cgmp production as a readout system |
| 06/09/2005 | WO2005052157A1 Il-23 and its receptor; related reagents and methods |
| 06/09/2005 | WO2005052023A1 Hyperbranched polymers |
| 06/09/2005 | WO2005051993A1 Novel muscle growth regulator |
| 06/09/2005 | WO2005051980A1 Depeptidized inhibitors of hepatitis c virus ns3 protease |
| 06/09/2005 | WO2005051978A2 Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof |
| 06/09/2005 | WO2005051974A2 Novel molecules for regulating cell death |
| 06/09/2005 | WO2005051972A1 Estrogen receptor modulators |
| 06/09/2005 | WO2005051969A1 Novel analgesic compounds, extracts containing same and methods of preparation |
| 06/09/2005 | WO2005051959A1 Β-lactamase-resistant cephalosporin ester compounds and salts of thereof |
| 06/09/2005 | WO2005051958A2 Particle-forming compositions containing fused pyrrolocarbazoles |
| 06/09/2005 | WO2005051957A1 Indolyl-thieno`3,4-b!pyrazin-3-one derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 06/09/2005 | WO2005051955A1 Novel compound and medicinal composition |
| 06/09/2005 | WO2005051953A2 Pyrrolo-pyrazine derivatives useful as cb1-modulators |
| 06/09/2005 | WO2005051950A1 Novel 8-(piperazine-1-yl)- and 8-([1,4]diazepan-1-yl)-xanthine, the production and use thereof in the from of a drug |
| 06/09/2005 | WO2005051949A1 Novel condensed imidazole derivative |
| 06/09/2005 | WO2005051947A1 Thiaepothilone for treating cancerous diseases |
| 06/09/2005 | WO2005051946A2 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 06/09/2005 | WO2005051944A1 Heterocyclyl-substituted oxetanes for the treatment of proliferative or infectious diseases |
| 06/09/2005 | WO2005051940A2 Vitamin d receptor modulators |
| 06/09/2005 | WO2005051938A1 Vitamin d receptor modulators |
| 06/09/2005 | WO2005051934A1 Antithrombotic compounds with dual function |
| 06/09/2005 | WO2005051927A1 Method of culturing cd4-positive t cells via stimulation culture of hiv-1-infected pheripheral monocytes and hiv-1 growth inhibitor |
| 06/09/2005 | WO2005051922A1 Quinazolinone compounds as anticancer agents |
| 06/09/2005 | WO2005051921A1 Crystalline ammonium salts of rosuvastatin |
| 06/09/2005 | WO2005051920A2 Specific antagonist for both e- and p-selectins |